Suppr超能文献

药物转运体在血视网膜屏障中的作用。

Roles of Drug Transporters in Blood-Retinal Barrier.

机构信息

China Pharmaceutical University, Nanjing, China.

出版信息

Adv Exp Med Biol. 2019;1141:467-504. doi: 10.1007/978-981-13-7647-4_10.

Abstract

Blood-retinal barrier (BRB) includes inner BRB (iBRB) and outer BRB (oBRB), which are formed by retinal capillary endothelial (RCEC) cells and by retinal pigment epithelial (RPE) cells in collaboration with Bruch's membrane and the choriocapillaris, respectively. Functions of the BRB are to regulate fluids and molecular movement between the ocular vascular beds and retinal tissues and to prevent leakage of macromolecules and other potentially harmful agents into the retina, keeping the microenvironment of the retina and retinal neurons. These functions are mainly attributed to absent fenestrations of RCECs, tight junctions, expression of a great diversity of transporters, and coverage of pericytes and glial cells. BRB existence also becomes a reason that systemic administration for some drugs is not suitable for the treatment of retinal diseases. Some diseases (such as diabetes and ischemia-reperfusion) impair BRB function via altering tight junctions, RCEC death, and transporter expression. This chapter will illustrate function of BRB, expressions and functions of these transporters, and their clinical significances.

摘要

血-视网膜屏障(BRB)包括内 BRB(iBRB)和外 BRB(oBRB),分别由视网膜毛细血管内皮(RCEC)细胞和视网膜色素上皮(RPE)细胞与 Bruch 膜和脉络膜合作形成。BRB 的功能是调节眼血管床和视网膜组织之间的液体和分子运动,并防止大分子和其他潜在有害物质渗漏到视网膜中,保持视网膜和视网膜神经元的微环境。这些功能主要归因于 RCEC 无窗孔、紧密连接、表达大量不同的转运体以及周细胞和神经胶质细胞的覆盖。BRB 的存在也是全身性给药不适合治疗视网膜疾病的原因之一。一些疾病(如糖尿病和缺血再灌注)通过改变紧密连接、RCEC 死亡和转运体表达来损害 BRB 功能。本章将说明 BRB 的功能、这些转运体的表达和功能及其临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da72/7120327/febad754697d/432740_1_En_10_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验